Exosome-Based Skin Rejuvenation: Promise, Pitfalls, and Path to Clinical Integration

Nupura Ajesh *¹, Samiksha Ravindra Balaguragi ², Meenakshi Jayachandran Nair ¹, Gopika Joshy ¹, Riya Mariam Philip ¹, Subramaniyam Kokilakrishnan Yogeshwar ¹

1. Department of Medicine, Faculty of Medicine, Tbilisi State Medical University, Tbilisi, Georgia,
2. Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia.

*Correspondence to: Nupura Ajesh. Department of Medicine, Faculty of Medicine, Tbilisi State Medical University, Tbilisi, Georgia.

Copyright.

© 2026 Nupura Ajesh, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 23 April 2026

Published: 01 May 2026

DOI: https://doi.org/10.5281/zenodo.19915711

Abstract

Exosome therapy is a new avenue in regenerative dermatology that uses extracellular vesicles encapsulating proteins, lipids, and nucleic acids to enhance cellular communication, especially in cosmetic dermatology, where exosomes have shown promising results in improving skin texture, elasticity, healing, and pigmentation. Multiple clinical studies involving microneedling and split-face trials have shown beneficial results. However, rare but possibly severe complications have been noted, like skin necrosis after intradermal injection of lyophilized exosomes, which are to be kept in mind.

This paper reviews current evidence, clinical integration possibilities, reliability, outcomes, and challenges.

Keywords: Exosome therapy, skin rejuvenation, microneedling, safety, methodology, ethics, dermatology.

Introduction

Exosomes are small extravesicular vesicles that are 30 to 150nm in size and are secreted by most cells and carry biomolecules central to intracellular signaling, like proteins, nucleic acids, and lipids. In cosmetic dermatology, exosomes have become a promising agent for skin regeneration by enhancing collagen production, improving elasticity, reducing inflammation, and accelerating healing [1.2].

Method

A structured literature search was conducted in PubMed, Scopus, Web of Science, and Google Scholar between January 2015 and July 2025. The search terms included: exosome therapy, skin rejuvenation, microneedling, adverse events, and dermatology. Inclusion criteria comprised clinical trials, randomized controlled trials (RCTs), observational studies, and relevant case reports focusing on exosome-based interventions for dermatological applications in humans. Preclinical studies were included for mechanistic insights. Only studies published in English were considered.

Results

Split - Face and Miconeedling Trials

A 2023 study demonstrated that human adipose-derived exosomes with microneedling significantly improved facial skin aging while remaining safe [3]. In 2020, it was reported that adipose-derived stem cell exosomes led to effective skin brightening in a prospective, randomized, split-face study. It was also noted that exosomes used as an adjuvant to carbon dioxide(CO2) laser for acne scars decreased scars significantly and reduced downtime in comparison to other controls [4,5].

Comparative Studies

A 2025 trial showed that adipose mesenchymal stem cell-derived exosomes improved wrinkles, erythema, dyschromia, and texture much better compared to platelet-rich plasma (PRP) [6].

Prencipal and Mechanistic Studies

Exosome therapy has shown great promise in wound healing and reduced scarring by mechanisms like activation of the Hippo pathway and inhibiting TGF-β signaling in animal models [7,8]. The highlight is on how exosomes play a role in regenerative therapies and their therapeutic possibilities [9].

Indications of Exosome Theraphy

As exosome therapy is an emerging regenerative medicine, it has multiple applications, not just in dermatology, but also in cardiology and rheumatology. Studies have shown reduced risk of heart tissue damage and promotion of cardiac muscle cells. In dermatology, exosome therapy promotes tissue repair and aids in the healing of chronic wounds, burns, and even ulcers.

Adverse Effects

A concerning side effect was noted in a case report in early 2024 describing skin necrosis, leukocytoclastic vasculitis, and eccrine necrosis following intradermal injection of lyophilized exosomes. This sheds light on safety risks that need to be kept in mind with such formulations [10].

Difference between Exosomes and Boosters

Exosomes are tiny vesicles that are released by cells that carry proteins and genetic material, which help in cell communication and repair. On the other hand, boosters are given to prolong or enhance a body’s response. Basically, they are external enhancers of biological functions, while exosomes are natural cell messengers [11].

Literature Overview

The included studies consisted of 5 randomized controlled trials, 2 non-randomized clinical studies, and 2 case reports. Study interventions ranged from topical application to intradermal injections, often combined with procedures like microneedling or CO? laser therapy [Table 1].

Discussion

Exosome therapy, when combined with microneedling or laser treatments, has become popular in cosmetic dermatology for improving skin aging, scarring, and texture with minimal downtime. There have been multiple positive reports from controlled and comparative trials.

Recognized trials have shown moderate-level evidence for efficacy. Yet differences in exosome source, dosage, preparation, and application limit reproducibility. Standard manufacturing and administration protocol is essential [1]. 

Clinical studies reported consistent enhancements in brightness, texture, a decrease in scars, and good recovery time, performing better than traditional known treatments like PRP or laser alone [10].

Regulatory bodies such as the FDA have made it clear that exosomes are drug products that require pre-market approval. In the United Kingdom and the European Union, human-derived exosome therapies are banned due to the potential risk of disease transmission and public safety.

While exosome therapy shows a lot of promise for skin rejuvenation, its cons need to be noted too. There is a high risk for skin necrosis and disease transmission, hence the need for proper standardized protocols for dosing and preparation [3].

Conslusion

Exosome therapy in dermatology has great potential in enhancing skin rejuvenation, scar reduction, and healing with less downtime. However, safety concerns related to the administration route and product quality, along with regulation gaps is need to be kept in mind. To ensure safe and effective use, properly defined protocols, comprehensive clinical trials, and clear regulatory oversight are needed.

Acknowlegdments

Ethical approval:

Institutional review board approval is not required.

Declaration of patient consent:

A declaration of patient consent is not required.

Conflicts of interest:

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Financial support and sponsorship: Nil.

References

1. Nguyen ST. Exosomes derived from mesenchymal stem cells: A novel agent for skin aging treatment. Biomedical Research and Therapy. 2024 Dec 31;11(12):7003–14.
2. Harsha Sreeraj, R. AnuKiruthika, K.S. Tamilselvi, D. Subha. EXOSOMES FOR SKIN TREATMENT: THERAPEUTIC AND COSMETIC APPLICATIONS. Nano TransMed. 2024 Sep 1;100048–8.
3. Park GH, Hyuck Hoon Kwon, Seok J, Steven Hoseong Yang, Lee J, Byung Chul Park, et al. Efficacy of combined treatment with human adipose tissue stem cell?derived exosome?containing solution and microneedling for facial skin aging: A 12?week prospective, randomized, split?face study. 2023 Jun 28
4. Park GH, Hyuck Hoon Kwon, Seok J, Steven Hoseong Yang, Lee J, Byung Chul Park, et al. Efficacy of combined treatment with human adipose tissue stem cell?derived exosome?containing solution and microneedling for facial skin aging: A 12?week prospective, randomized, split?face study. 2023 Jun 28
5. Cho BS, Lee J, Won Y, Duncan DI, Jin RC, Lee J, et al. Skin Brightening Efficacy of Exosomes Derived from Human Adipose Tissue-Derived Stem/Stromal Cells: A Prospective, Split-Face, Randomized Placebo-Controlled Study. Cosmetics [Internet]. 2020 Dec 1 [cited 2021 May 28];7(4):90. Available from: https://www.mdpi.com/2079-9284/7/4/90
6. Kim JS ., Oh SY ., Lee SH ., Kang JH ., Kim DU, Jeong SH ., et al. Randomized clinical trial for apogeotropic horizontal canal benign paroxysmal positional vertigo. Neurology [Internet]. 2012 Jan 17;78(3):159–66. Available from: https://pubmed.ncbi.nlm.nih.gov/22170885/
7. Estupiñan B, Ly K, Goldberg DJ. Adipose Mesenchymal Stem Cell-Derived Exosomes Versus Platelet-Rich Plasma Treatment for Photoaged Facial Skin: An Investigator-Blinded, Split-Face, Non-Inferiority Trial. Journal of cosmetic dermatology [Internet]. 2025 May;24(5):e70208. Available from: https://pubmed.ncbi.nlm.nih.gov/40414798/
8. Zhang B, Gong J, Li H, Khan A, Xiong T, Shen H, et al. Exosomes based advancements for application in medical aesthetics. 2022 Dec 20;10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810265/
9. Cho BS, Lee J, Won Y, Duncan DI, Jin RC, Lee J, et al. Skin Brightening Efficacy of Exosomes Derived from Human Adipose Tissue-Derived Stem/Stromal Cells: A Prospective, Split-Face, Randomized Placebo-Controlled Study. Cosmetics [Internet]. 2020 Dec 1 [cited 2021 May 28];7(4):90. Available from: https://www.mdpi.com/2079-9284/7/4/90
10. Taciana Dal'Forno-Dini, Birck MS, Rocha M, Edileia Bagatin. Exploring the reality of exosomes in dermatology. Anais Brasileiros de Dermatologia. 2024 Nov 1;
11. Yi K, Waranaree Winayanuwattikun, Kim S, Wan J, Vanravi Vachatimanont, Ardhiah Iswanda Putri, et al. Skin boosters: Definitions and varied classifications. Skin research and technology. 2024 Mar 1;30(3).